Five vendors with repeated laboratory failures
A dated comparison of identity and labeled-amount failures across the five vendor operations named in the investigation.
Independent lab evidence
Peptides For Sale’s lab evidence dates to February 2025 and covers 23 test records across 5 recorded compound names, alongside 0 community reviews. Median purity is 97.4% across 14 positive purity tests.
▸ What you can check next
23 published records · 0 excluded by the current index · Names on reports; vendor role unverified. A test record is not necessarily a unique certificate.
2 classified tests
23 reported purity outcomes
0 fill tests · Last 6 months
0 fill tests · Last 6 months
23 numeric amount results
Measured against the printed amount. Finnrick quantities are excluded.
Mean 89.4% · Median 97.4%. The 90% grouping is not a safety threshold.
0 records have no usable purity outcome. 23 do not have a comparable fill test. 21 lack a classified endotoxin result. A classified pass does not mean no endotoxin was detected.
Buyer experiences—not lab results or verified purchases.
No approved reviews on file yet.
Recorded offers—not a live stock guarantee. Package quantity, delivery market and price basis stay attached.
Listing layout preview. Actual offers appear after access is checked.
2025-02-27 — 2026-05-13
Published investigations, with the sources and context behind the findings.
Answers based on the published evidence—not a vendor endorsement.
TitrateLab does not rank or recommend vendors; it reports what independent labs measured. Peptides For Sale shows low measured purity (89.4% mean across 14 positive purity measurements; 9 identity failures reported separately). No dose results are on file, so label accuracy cannot be assessed. These results describe tested batches, not every product or shipment.
89.4% mean measured purity across 14 positive third-party lab results; 11 were at or above 90% and 3 were below. In 9 additional tests, the labeled compound was not detected.
23 third-party certificates from 2025-02-27 to 2026-05-13, covering 5 compounds.
No dose results are on file, so label accuracy cannot be assessed. A dose result compares the measured amount with the amount printed on the label: under is more than 10% below, over is more than 10% above, on target is everything in between. Finnrick results are excluded because that lab measures against the vendor's batch claim. Missing values are never counted as passes.
Endotoxin was reported on 2 of 23 counted records (8.7%). No failures were recorded in those 2. Coverage is too limited for a vendor-wide conclusion.
23 published records are attributed to this vendor. The current certificate index excludes 0 repeated records using file hashes and supported lab verification links. Missing identity keys can leave repeated certificates. Recorded name groups can include variants, mixtures and unclassified names.
Evidence dates describe the tested samples, not when the vendor was founded, current stock, or a performance trend. Purity uses positive measurements only. Exact-zero purity is a not-detected identity outcome, not proof of an empty vial. A zero measured amount requires an explicit numeric amount result; missing amounts are not zero.
Underfills and overfills here exceed 15% in either direction against the printed amount. Vendor batch claims are not used; Finnrick quantity comparisons are excluded. Recent outcomes cover 2026-03-17 through 2026-09-17, inclusive. The older published ±10% partition may appear in the existing FAQ and is a different, explicitly labelled threshold. Missing tests are not passing results.
Endotoxin failures, borderline outcomes and passes use the recorded lab verdict. A pass is not proof of no endotoxin. Only 2 records have a classifiable result. Community sentiment describes reviews, not laboratory measurements or independently verified purchases. Results are not certification, medical advice or endorsement.
Missing measurements stay missing. Membership unlocks access, not additional testing.